Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
24
pubmed:dateCreated
2003-6-12
pubmed:abstractText
Faced with unsatisfactory results of treatment for advanced Hodgkin's disease, we investigated three combinations of chemotherapy.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1533-4406
pubmed:author
pubmed:copyrightInfo
Copyright 2003 Massachusetts Medical Society
pubmed:issnType
Electronic
pubmed:day
12
pubmed:volume
348
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2386-95
pubmed:dateRevised
2009-5-22
pubmed:meshHeading
pubmed-meshheading:12802024-Aged, pubmed-meshheading:12802024-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:12802024-Bleomycin, pubmed-meshheading:12802024-Combined Modality Therapy, pubmed-meshheading:12802024-Cyclophosphamide, pubmed-meshheading:12802024-Dacarbazine, pubmed-meshheading:12802024-Dose-Response Relationship, Drug, pubmed-meshheading:12802024-Doxorubicin, pubmed-meshheading:12802024-Etoposide, pubmed-meshheading:12802024-Female, pubmed-meshheading:12802024-Hodgkin Disease, pubmed-meshheading:12802024-Humans, pubmed-meshheading:12802024-Leukemia, pubmed-meshheading:12802024-Male, pubmed-meshheading:12802024-Middle Aged, pubmed-meshheading:12802024-Neoplasm Staging, pubmed-meshheading:12802024-Neoplasms, Second Primary, pubmed-meshheading:12802024-Prednisone, pubmed-meshheading:12802024-Procarbazine, pubmed-meshheading:12802024-Survival Analysis, pubmed-meshheading:12802024-Vinblastine, pubmed-meshheading:12802024-Vincristine
pubmed:year
2003
pubmed:articleTitle
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
pubmed:affiliation
First Department of Internal Medicine, University of Cologne, Cologne, Germany. v.diehl@uni-koeln.de
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study